Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a research note published on Saturday. The brokerage issued a hold rating on the stock.

Several other equities analysts have also recently issued reports on the company. HC Wainwright reiterated a “buy” rating and set a $9.00 target price on shares of Ekso Bionics in a research report on Tuesday, January 14th. Lake Street Capital dropped their target price on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th.

Ekso Bionics Stock Down 0.6 %

EKSO opened at $0.57 on Friday. The business has a 50 day moving average price of $0.63 and a two-hundred day moving average price of $0.86. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. The company has a market cap of $12.55 million, a PE ratio of -0.88 and a beta of 1.46. Ekso Bionics has a 52 week low of $0.47 and a 52 week high of $2.16.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.